<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim BK</submitter><funding>Health Technology R&amp;amp;D Grant</funding><funding>Health Technology R&amp;D Grant</funding><funding>National Research Foundation</funding><funding>Korea Research Institute of Bioscience and Biotechnology</funding><pagination>212</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9241269</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Identifying biomarkers related to the diagnosis and treatment of gastric cancer (GC) has not made significant progress due to the heterogeneity of tumors. Genes involved in histological classification and genetic correlation studies are essential to develop an appropriate treatment for GC.&lt;h4>Methods&lt;/h4>In vitro and in vivo lentiviral shRNA library screening was performed. The expression of Synaptotagmin (SYT11) in the tumor tissues of patients with GC was confirmed by performing Immunohistochemistry, and the correlation between the expression level and the patient's survival rate was analyzed. Phospho-kinase array was performed to detect Jun N-terminal kinase (JNK) phosphorylation. SYT11, JNK, and MKK7 complex formation was confirmed by western blot and immunoprecipita</pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pubmed_title>Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis.</pubmed_title><pmcid>PMC9241269</pmcid><funding_grant_id>KGM5192221</funding_grant_id><funding_grant_id>NRF-2019R1A2C1087492</funding_grant_id><funding_grant_id>HI13C2162</funding_grant_id><pubmed_authors>Park H</pubmed_authors><pubmed_authors>Kim SY</pubmed_authors><pubmed_authors>Jung H</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Kweon DH</pubmed_authors><pubmed_authors>Kim BK</pubmed_authors><pubmed_authors>Kim DM</pubmed_authors><pubmed_authors>Byun JE</pubmed_authors><pubmed_authors>Hwang MA</pubmed_authors><pubmed_authors>Yeom YI</pubmed_authors><pubmed_authors>Cheong JH</pubmed_authors><pubmed_authors>Kang MJ</pubmed_authors><pubmed_authors>Kang M</pubmed_authors><pubmed_authors>Kim SK</pubmed_authors><pubmed_authors>Im JY</pubmed_authors><pubmed_authors>Won M</pubmed_authors><pubmed_authors>Park KC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis.</name><description>&lt;h4>Background&lt;/h4>Identifying biomarkers related to the diagnosis and treatment of gastric cancer (GC) has not made significant progress due to the heterogeneity of tumors. Genes involved in histological classification and genetic correlation studies are essential to develop an appropriate treatment for GC.&lt;h4>Methods&lt;/h4>In vitro and in vivo lentiviral shRNA library screening was performed. The expression of Synaptotagmin (SYT11) in the tumor tissues of patients with GC was confirmed by performing Immunohistochemistry, and the correlation between the expression level and the patient's survival rate was analyzed. Phospho-kinase array was performed to detect Jun N-terminal kinase (JNK) phosphorylation. SYT11, JNK, and MKK7 complex formation was confirmed by western blot and immunoprecipita</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2026-05-27T21:39:11.496Z</modification><creation>2022-07-08T11:35:45.229Z</creation></dates><accession>S-EPMC9241269</accession><cross_references><pubmed>35768842</pubmed><doi>10.1186/s13046-022-02420-3</doi></cross_references></HashMap>